Home Health Care News April 16, 2024
It was a turbulent start to the year for the health care giant UnitedHealth Group, driven by the cyberattack on Change Healthcare and a U.S. Department of Justice (DOJ) antitrust investigation.
Amid the DOJ investigation, UnitedHealth Group’s planned acquisition of the home health company Amedisys Inc. (Nasdaq: AMED) came into focus, with reports circulating that the DOJ was considering an attempt to block that deal specifically.
Signs still suggest that deal is on track to be completed by the end of the year, albeit with certain divestments likely in order for Amedisys.
“We don’t comment on these sorts of matters,” UnitedHealth Group CEO Andrew Witty said Tuesday during the company’s first quarter-earnings call, referring to the DOJ investigation. “I don’t...
Today's Sponsors
Today's Sponsor